Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-16-457598
Filing Date
2016-02-10
Accepted
2016-02-10 16:15:40
Documents
3
Group Members
KEVIN P. STARRMARK LEVINROBERT I. TEPPERTHIRD ROCK VENTURES GP II, L.P.TRV GP II, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d54285dsc13ga.htm SC 13G/A 112800
2 EX-24 d54285dex24.htm EX-24 3665
3 EX-99.1 d54285dex991.htm EX-99.1 7078
  Complete submission text file 0001193125-16-457598.txt   125179
Mailing Address 29 NEWBURY STREET 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures II, L.P. (Filed by) CIK: 0001488495 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Subject) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88275 | Film No.: 161405914
SIC: 2834 Pharmaceutical Preparations